Welcome to the ProBio Biologics Symposium 2025!

Date: Thursday 28 August 2025 | Time: 13:00-17:10 (KST/GMT+9)

This symposium shares practical, case-based insights in next-generation biologics, from ADC to VHH and antibody fragments. You’ll learn tactics for conjugation, formulation, and analytics to move faster from discovery to IND and GMP.

Put your biologics on the fast track to IND.

Session Replays & Abstracts

  • session-image

  • Session #1 — One-Stop Solution for ADC Discovery

    1. Concise review of the history and latest trends in antibody-drug conjugates

    2. Key tools and strategies for ADC discovery and pharmacology assessment

    3. Case study highlighting ADC discovery and characterization

    ADC Discovery

  • Session #2 — Challenges and Solutions for Complex Biologic CMC

    1. Overview of CMC challenges for complex biologics

    2. Platform solution for CMC challenges with case studies

    CMC Case Study
  • session-image
  • session-image

  • Session #3 — Integrated sdAb Discovery via Phage Library and Single B Cell Screening Technology

    1. Overview of the development and emerging trends in sdAb-based therapeutic antibodies

    2. Single B cell approach to sdAb discovery

    3. Phage display based sdAb discovery

    sdAb/VHH Discovery

  • Session #4 — ProBio Platform Solution for VHH and Ab Fragments

    1. Overview of Ab fragment properties and their applications

    2. CMC challenges and strategies for Ab fragments

    3. Case studies

    IND-enabling CMC
  • session-image
Contact us

Program at a Glance

Time Talk Speaker
13:00-13:30 Registration
13:30-13:35 Opening Remark Jennifer Ju
Director, head of Korea, ProBio
13:35-14:10 One-Stop Solution for ADC Discovery Derek Chen
Sr. Director, Antibody Drug Discovery Dept., ProBio
14:10-14:50 Challenges and Solutions for Complex Biologics CMC Ying Li
Director of Antibody PD Dept., ProBio
14:50-15:40 Networking and Refreshment Break (Canapés Served)
15:40-16:20 Integrated sdAb Discovery via Phage Library and Single B Cell Screening Technology Derek Chen
16:20-16:55 ProBio Platform Solution for VHH and Ab Fragments Ying Li
16:55-17:10 Lucky Draw & Closing Remark

Speakers

  • Derek Chen

    Derek Chen
    Sr. Director, Antibody Drug Discovery Dept., ProBio

  • Ying Li

    Ying Li
    Director of Antibody PD Dept., ProBio

  • Jennifer Ju

    Jennifer Ju
    Director, head of Korea, ProBio

Related service